Payments Will Facilitate Beneficiary Access to Argus II in both Inpatient and Outpatient Settings Sylmar, CA- August 15, 2013—Second Sight Medical Products, Inc. today announced that The Argus® II Retinal Prosthesis System (Argus II) has been approved by the Centers for Medicare and Medicaid Services (CMS) beginning October 1, 2013. These payments are designed to support [Read More]
News
Study of aquaporins could hold clues to cataract
Researchers have achieved dynamic, atomic-scale views of a protein needed to maintain the transparency of the lens in the human eye. The work, funded in part by the National Institutes of Health, could lead to new insights and drugs for treating cataract and a variety of other health conditions. Aquaporin proteins form water channels between [Read More]
Recognizing Cataract
Watch for Vision Changes as You Age As life goes on, we all start to notice certain changes that are a natural part of aging. Maybe our joints aren’t as flexible as before, or our hearing just isn’t what it used to be. Our vision, too, may be less sharp than it once was. One [Read More]
Disparities in Eye Care Could Cost Some Their Sight
Low-income, less educated don’t have same access to preventive treatments, researchers report By Robert Preidt THURSDAY, July 18 (HealthDay News) — Americans with low incomes and education levels are less likely to get eye care, a new study finds. Researchers examined data from nearly 3,600 people, aged 40 and older, who took part in the [Read More]
Gene Therapy Without Retinal Risk
Researchers have developed a method of delivering genes to the inner layers of the retina without the risks associated with injection into the delicate tissues themselves. This less invasive technique has been carried out successfully in animal models by a research team led by Drs. John G. Flannery and David V. Schaffer at the University [Read More]